RecallWatchUSA

Home / Categories / Drugs

Drugs Recalls

17,897 recalls, newest first.

August 14, 2019DrugsFDA
RXQ Compounding LLC recalls GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls FOLIC ACID 5MG/ML INJECTION SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 4
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 4
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Stree
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls fentaNYL 0.05MG/ML INJ SOL (PF), 55ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 4570
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, At
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC:
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EPHEDRINE 5MG/ML (PF) SYRINGE, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC:
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls Edetate Disodium150mg/mL PFV, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 707
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC:
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EDETATE DISODIUM 15% INJECTABLE, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC:
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EDETATE DISODIUM 30% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC:
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, O
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL, 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athe
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls DEXTROSE 50% INJECTION SOLUTION (PF) VIAL, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens,
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls DEXPANTHENOL 250MG/ML (MDV) INJECTION SOLN, 30ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls Copper 0.4MG/ML (PVF) INJECTION SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 457
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls CALCIUM GLUCONATE 5% INJECTION SOLUTION (MDV), 20 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, O
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls CALCIUM CHLORIDE 100MG/ML (PFV) INJ SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 457
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls BUFFERED LIDOCAINE HCL 1% INJECTION SOL (PF) SYR, 0.5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athen
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls BUFFERED LIDOCAINE HCL 1% INJECTION SOLUTION (PF), 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Comp
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per
Hazard: Lack of Assurance of Sterility
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH
Hazard: Crystallization
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls Ascorbic Acid 400 MG/ML (Non-Corn) Injection Solution, 65 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, A
Hazard: Crystallization
August 14, 2019DrugsFDA
RXQ Compounding LLC recalls Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athe
Hazard: Crystallization
August 14, 2019DrugsFDA
Unipharma, Llc. recalls CVS Health Children's Nasal Saline Drops with Himalayan Salt Saline Nasal Moisturizer, 30 single-use vials per Carton,0.
Hazard: CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.